Drug Delivery Devices Market Forecast Highlights A $128.94 Billion Opportunity For Industry Participants
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Drug Delivery Devices Market Forecast: Value Set To Climb From $102.15 Billion To $128.94 Billion
The drug delivery devices market has experienced robust expansion in recent times. Projections indicate it will expand from $95.99 billion in 2025 to $102.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. This historical growth is attributable to an escalating prevalence of chronic illnesses, the broadening scope of injectable therapies, the uptick in hospital-based drug administration, greater utilization of infusion devices, and continuous improvements in pharmaceutical formulations.
The market for drug delivery devices is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $128.94 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth during the forecast period stems from factors such as the increasing uptake of home-based drug delivery, greater investments in personalized medicine, the broadening availability of biologics and biosimilars, an escalating need for connected delivery devices, and the expanding integration of digital health platforms. Key trends anticipated during this period encompass the wider adoption of intelligent drug delivery devices, a surge in the utilization of self-administration injection systems, an increasing call for controlled release technologies, the expansion of wearable drug delivery platforms, and a heightened emphasis on designs centered around the patient.
Get A Free Sample Report With In-Depth Market Insights:
Drug Delivery Devices Market Growth Momentum: What Factors Are Shaping Demand?
The drug delivery devices market is anticipated to expand due to an increase in healthcare spending. This spending encompasses all financial outlays for health services and products, such as costs for hospitals, doctors, nursing care, medicines, and public health initiatives. The rise in healthcare expenditure stems from an aging demographic, the growing occurrence of chronic illnesses, progress in medical technology, and elevated expenses for medical services and pharmaceuticals. Elevated healthcare spending fosters the evolution of drug delivery devices through increased investment in research, inventive solutions, and the integration of sophisticated technologies, thereby enhancing treatment effectiveness and patient results. For example, data from May 2024, released by the Office for National Statistics, a UK-based government department, indicated that UK healthcare expenditure reached around $379 billion (£292 billion) in 2023. This represented a 5.6% nominal increase compared to 2022, marking a substantial improvement over the 0.9% growth observed in 2023. Consequently, the expansion of healthcare spending is propelling the growth of the drug delivery devices market.
Drug Delivery Devices Market Segmentation And Category Overview
The drug delivery devices market covered in this report is segmented –
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants
Drug Delivery Devices Market Trends Redefining Industry Growth
Major companies operating in the drug delivery devices market are prioritizing the development of advanced solutions, including targeted oral release capsules, to boost treatment efficacy and minimize systemic side effects. These specialized capsules are designed to endure the stomach’s acidic environment and accurately release active ingredients into specific sections of the gastrointestinal tract, thereby improving bioavailability and localizing therapy. For example, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, unveiled its new EUDRACAP colon capsules, intended for delivering sensitive active substances to the ileo-colonic region. These capsules support the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while preserving their integrity through tailored EUDRAGIT coatings. Furthermore, the EUDRACAP colon capsules streamline formulation development with a ready-to-fill design and accelerate speed to market by reducing developmental complexity. This innovation broadens Evonik’s EUDRACAP platform and strengthens its portfolio of system solutions for advanced oral drug delivery.
Drug Delivery Devices Market Key Players Shaping Industry Direction
Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero
View The Full Drug Delivery Devices Market Report:
Drug Delivery Devices Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
